Back
PagerDuty, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
17
PD
PagerDuty, Inc.
Last Price:
$13.02
Seasonality Move:
-6.79%
Buy
65
GPCR
Structure Therapeutics, Inc.
Last Price:
$67.43
Seasonality Move:
-40.78%
Sell
17
PagerDuty, Inc. (PD)
is a Sell
Is PagerDuty, Inc. a Buy, Sell or Hold?
-
The current PagerDuty, Inc. [PD] share price is $13.03. The Score for PD is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
PD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $67.44. The Score for GPCR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PD Stock Price Chart
What is PagerDuty, Inc.'s stock price today?
-
The PagerDuty, Inc. share price today is $13.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PD is experiencing slight selling pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $67.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
PD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 41.74 | Sell |
| Chaikin Money Flow: | -628718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.42 - 15.52) | Sell |
| Bollinger Bands (100): | (14.28 - 16.78) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.09 | Buy |
| Relative Strength Index (14 RSI): | 78.81 | Buy |
| Chaikin Money Flow: | -1662506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.48 - 52.38) | Buy |
| Bollinger Bands (100): | (16.92 - 37.88) | Buy |
PD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.5 | Buy |
| 20-day SMA: | 13.55 | Sell |
| 50-day SMA: | 14.96 | Sell |
| 200-day SMA: | 15.79 | Sell |
| 8-day EMA: | 12.84 | Buy |
| 20-day EMA: | 13.43 | Sell |
| 50-day EMA: | 14.49 | Sell |
| 200-day EMA: | 16 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.53 | Buy |
| 20-day SMA: | 41.36 | Buy |
| 50-day SMA: | 34.58 | Buy |
| 200-day SMA: | 24.42 | Buy |
| 8-day EMA: | 55.53 | Buy |
| 20-day EMA: | 45.05 | Buy |
| 50-day EMA: | 36.57 | Buy |
| 200-day EMA: | 28.49 | Buy |
PagerDuty, Inc. Earnings Growth & PD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.07 per share, and an increase next year of $0.33 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
PagerDuty, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||